Advertisement
Research Article

Cost-Effectiveness of Apixaban Compared with Warfarin for Stroke Prevention in Atrial Fibrillation

  • Soyon Lee,

    Affiliations: School of Pharmacy, University of Connecticut, Storrs, Connecticut, United States of America, Hartford Hospital, Hartford, Connecticut, United States of America

    X
  • Rachel Mullin,

    Affiliation: School of Pharmacy, University of Connecticut, Storrs, Connecticut, United States of America

    X
  • Jon Blazawski,

    Affiliation: School of Pharmacy, University of Connecticut, Storrs, Connecticut, United States of America

    X
  • Craig I. Coleman mail

    ccolema@harthosp.org

    Affiliations: School of Pharmacy, University of Connecticut, Storrs, Connecticut, United States of America, Hartford Hospital, Hartford, Connecticut, United States of America

    X
  • Published: October 09, 2012
  • DOI: 10.1371/journal.pone.0047473

About the Authors

Soyon Lee, Rachel Mullin, Jon Blazawski, Craig I. Coleman
School of Pharmacy, University of Connecticut, Storrs, Connecticut, United States of America
Soyon Lee, Craig I. Coleman
Hartford Hospital, Hartford, Connecticut, United States of America

Corresponding Author

Email: ccolema@harthosp.org

Competing Interests

Dr. Coleman has received research funding from Janssen Pharmaceuticals Inc. and is a member of their Speaker's Bureau. No other authors have any conflicts of interest to report.

Author Contributions

Conceived and designed the experiments: SL CC. Performed the experiments: SL RM JB CC. Analyzed the data: SL RM JB CC. Contributed reagents/materials/analysis tools: SL RM JB CC. Wrote the paper: SL RM CC.